Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

Share Price is delayed by 15 minutes
Get Live Data
6,000.00    25.00 (0.42%)
Bid:
6,000.00
Ask:
6,005.00
Spread: 5.00 (0.083%)
Market Cap: £5.13b
DCC Live PriceLast checked at - London Stock Exchange

Intraday DCC Share Chart

AGM Trading Statement

10 Jul 2025 07:00

RNS Number : 4447Q
DCC PLC
10 July 2025
 

10 July 2025

AGM Trading Statement

DCC plc, the leading international sales, marketing and support services group, is issuing this update in advance of the Company's AGM to be held at 2.00 p.m. BST today.

First quarter ended 30 June 2025

In the seasonally less significant first quarter of the year, Group operating profit on a continuing basis was in line with expectations and modestly behind the prior year. DCC Energy traded in line with expectations and modestly below the prior year while DCC Technology traded in line with the prior year.

Outlook

DCC continues to expect that the year ending 31 March 2026 will be a year of good operating profit growth on a continuing basis, strategic progress and continued development activity.

Donal Murphy, Chief Executive, commented:

"Our simplification strategy is progressing to plan. We have reached agreement for the sale of DCC Healthcare, made good progress on the integration of our North American Technology businesses and put our new DCC Leadership Team in place. Our ambition is to be a global leader in the sales, marketing and distribution of energy products and services, delivering high growth and high returns for our shareholders. DCC has a unique energy business, providing multi-energy solutions for our customers. We will continue to grow our customer base by being the provider of choice for essential energy products and by selling more services to our energy customers, driving higher organic growth rates."

Strategy implementation and development

Following the announcement on 22 April 2025 that DCC had entered into a definitive agreement to dispose of DCC's Healthcare division, DCC still expects the transaction to complete in the second quarter of FY26, subject to the receipt of regulatory approvals. 

 

DCC commenced a £100 million share buyback programme on 27 May 2025, which is progressing in line with expectations and is now more than 33% complete. On 13 May 2025, the Group also committed to returning up to £600 million of surplus capital to shareholders following the completion of the disposal of DCC Healthcare. 

Leadership changes

As previously announced, Kevin Lucey, who has been the Chief Financial Officer (CFO) and an executive Director since 2020, will become Chief Operating Officer (COO) following today's AGM. Conor Murphy will succeed Kevin as CFO and will be appointed to the Board as an executive Director, again from the conclusion of our AGM later today.

Date for interim results

DCC expects to announce its interim results for the six months ending 30 September 2025 on Tuesday 11 November 2025.

Contact information

Investor enquiries:

 

Conor Murphy, Chief Financial Officer (Designate)

Tel: +353 1 2799 400

Rossa White, Head of Group Investor Relations & Comms.

Email: investorrelations@dcc.ie

Media enquiries:

Sodali & Co (Eavan Gannon/Pete Lambie)

Tel: +44 20 7250 1446

Email: DCCGroup@sodali.com

About DCC plc

Invested in Energy

DCC is a customer-focused energy business, specialising in the sales, marketing, and distribution of secure, cleaner and competitive energy solutions to commercial, industrial, domestic, and transport customers. Headquartered in Dublin, DCC is listed on the London Stock Exchange and is a constituent of the FTSE 100. In our financial year ended 31 March 2025, DCC generated revenues of £18.0 billion and adjusted operating profit of £617.5 million. DCC has an excellent record, delivering compound annual growth of 13% in continuing adjusted operating profit and unbroken dividend growth of 13% while maintaining high returns on capital employed over 31 years as a public company.

Follow us on LinkedIn.

www.dcc.ie

 

Forward-looking statements

This announcement contains some forward-looking statements that represent DCC's expectations for its business, based on current expectations about future events, which by their nature involve risk and uncertainty. DCC believes that its expectations and assumptions with respect to these forward-looking statements are reasonable, however because they involve risk and uncertainty as to future circumstances, which are in many cases beyond DCC's control, actual results or performance may differ materially from those expressed in or implied by such forward-looking statements.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPUCAMUPAGMB
Date   Source Headline
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSLaunch of £100 million Share Buyback Programme
23rd May 20255:10 pmRNSDirector/PDMR Shareholding
13th May 20257:00 amRNSResults for the year ended 31 March 2025
22nd Apr 20257:00 amRNSDisposal of DCC Healthcare
9th Apr 20257:00 amRNSDCC Leadership Changes
28th Feb 202511:00 amRNSTotal Voting Rights
5th Feb 20257:00 amRNSQ3 Trading Statement
9th Dec 202412:23 pmRNSDirector Declaration
29th Nov 20242:33 pmRNSTotal Voting Rights
18th Nov 20245:30 pmRNSDirector/PDMR Shareholding
12th Nov 20247:01 amRNSResults for the six months ended 30 September 2024
12th Nov 20247:00 amRNSStrategy Update: DCC to focus on Energy sector
20th Aug 20245:52 pmRNSHolding in Company TR-1
31st Jul 20242:20 pmRNSTotal Voting Rights
11th Jul 20244:53 pmRNSResult of AGM
11th Jul 20247:02 amRNSBoard Appointment
11th Jul 20247:01 amRNSDivestment of Hong Kong Energy Business
11th Jul 20247:00 amRNSAGM Trading Statement
12th Jun 202410:09 amRNS2024 Sustainability Report
12th Jun 202410:05 amRNS2024 Annual Report, Notice of AGM and Proxy Form
31st May 20245:00 pmRNSDirector/PDMR Shareholding
31st May 20244:30 pmRNSTotal Voting Rights
24th May 20245:00 pmRNSDirector/PDMR Shareholding
14th May 20247:00 amRNSResults for the year ended 31 March 2024
6th Mar 20244:52 pmRNSHolding in Company
28th Feb 20243:52 pmRNSTotal Voting Rights
7th Feb 20247:00 amRNSInterim Management Statement
31st Jan 20249:44 amRNSTotal Voting Rights
14th Dec 20237:00 amRNSBoard and Remuneration Committee Changes
30th Nov 202311:59 amRNSTotal Voting Rights
24th Nov 20235:34 pmRNSDirector/PDMR Shareholding
20th Nov 20235:45 pmRNSDirector/PDMR Shareholding
14th Nov 20237:01 amRNSAcquisition of Progas GmbH
14th Nov 20237:00 amRNSResults for the six months ended 30 September 2023
6th Sep 20237:00 amRNSDCC Energy Insights Day and Five New Acquisitions
31st Jul 20231:03 pmRNSTotal Voting Rights
13th Jul 20235:22 pmRNSResult of AGM
13th Jul 20237:00 amRNSAGM Trading Statement
14th Jun 202310:09 amRNS2023 Sustainability Report
14th Jun 202310:05 amRNS2023 Annual Report, Notice of AGM and Proxy Form
31st May 20234:38 pmRNSTotal Voting Rights
26th May 20234:58 pmRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSResults for the year ended 31 March 2023
9th May 20237:00 amRNSStatement regarding Chief Executive
25th Apr 20237:00 amRNSNotice of Full Year 2023 Results
28th Feb 20239:36 amRNSTotal Voting Rights
8th Feb 20237:00 amRNSBoard Appointment
8th Feb 20237:00 amRNSInterim Management Statement
6th Jan 20235:39 pmRNSHolding in Company TR-1

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.